Phase I an pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks

S (Suresh) Senan, R Rampling, MA Graham, P Wilson, H Robin, N Eckardt, N Lawson, A Mc Donald, R von Roemeling, P Workman, SB Kaye

Research output: Contribution to journalArticleAcademicpeer-review

38 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)31-38
Number of pages8
JournalClinical Cancer Research
Publication statusPublished - 1997
Externally publishedYes

Cite this